General information
All reagents were obtained from Adamas, Aladin, Accela, or Acros and used without further purification unless otherwise noted. The products were purified by column chromatography with Huanghai Silica Gel 50-75 um, ultrapure silica gel.
1 H and 13 C NMR spectra were recorded on an Agilent 400MR DD2 (400 MHz) or Agilent 600MR DD2 (600 MHz) spectrometer. Chemical shifts were reported in parts per million (ppm), and tetramethylsilane or the residual solvent peak was used as an internal reference.
1 H (tetramethylsilane δ 0.00), 13 C (chloroform δ 77.00). Data are reported as follows:
chemical shift, multiplicity (s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet, br = broad), coupling constants (Hz) and integration. High resolution mass spectra (HRMS) were performed on Bruker solarix 7.0T. X-ray crystallography analysis of single crystals was performed on an Agilent SuperNova-CCD X-Ray diffractometer. Melting points were measured using SGWX-4A Microscopic melting point meter and are uncorrected. No melting points were reported for amorphous solids. Enantiomeric excesses (ee) were determined by HPLC analysis on Hitachi Chromaster using DAICEL CHIRALCEL AD-H, 4.6 mm Ф × 250 mmL. All reactions were carried out under nitrogen atmosphere in oven-dried glassware with magnetic stirring. Unless otherwise stated, all solvents employed in the reactions were distilled from appropriate drying agents prior to use. 
Reaction condition screening

Synthesis of arylglyoxal monohydrate 3
The reactions were carried out according to a literature method. 1 To a 50 mL three-neck flask with a condenser was added 1,4-dioxane (12.5 mL), SeO2 (2.75 g, 0.25mol) and water (1.5 mL). The mixture was heated at 50-55 o C and stirred until the solid was dissolved, then acetophenone (0.25 mol) was added and the reaction mixture was refluxed for 4 h. The solid was removed by filtration, the filtrate was concentrated. The residue was purified by silica gel column chromatography (acetone:hexane/1:10) to give arylglyoxal monohydrate 3.
Transformations of 2a
S4
Ethyl 2-((tert-butyldimethylsilyl)oxy)-2-(1H-indol-1-yl)acetate (5)
The reactions were carried out according to a literature method. 2 A solution of 2a 2g (9.12 mmol), 1.84 g (12.22 mmol) of tertbutylchlorodimethylsilane, 3.2 mL (23.35 mmol) of triethylamine, and 111.4 mg (0.91 mmol) of 4-(dimethylmino) pyridine in 15 mL of anhydrous tetrahydrofuran was stirred under a dry nitrogen atmosphere for 12 h, at the end of which time NH4Cl was added. The mixture was extracted with EtOAc (3 × 25 mL). The combined organics were washed with brine (40 mL), dried over Na2SO4, and filtered. Removal of solvent by rotary evaporation and purification by flash column chromatography (silica gel, PE/EtOAc, 40:1) to afford 5 (2.33 g) in 77% yield.
2-((tert-butyldimethylsilyl)oxy)-2-(1H-indol-1-yl)ethan-1-ol (6)
The reactions were carried out according to a literature method. 2 To a cooled suspension of LiAlH4 (114 mg, 3.0 mmol) in dry ether (13 mL) was dropped a solution of 5 (1.0 g, 3.0 mmol) in dry ether (2 mL) slowly under an argon atmosphere. The mixture was stirred for 30 min at the same temperature. Sat. aq. potassium sodium tartrate (10 mL) was added to the reaction mixture and the mixture was extracted with ether three times (10 mL x 3). The combined organic layer was washed with water and brine, dried over Na2SO4 , and concentrated in vacuo. The residual oil was purified by column chromatography on silica gel eluted with (PE/EtOAc, 20:1) to afford 6 (813 mg) in 93% yield. .18 (dp, J = 24.7, 7.3 Hz, 2H), 1.12 (t, J = 6.9 Hz, 3H). 13 C NMR (100 MHz, CDCl3): δ 169. 58, 135.34, 129.19, 125.31, 122.32, 121.06, 120.47, 109.77, 103.65, 76.40, 63.03, 13.79 135.82, 129.70, 122.53, 122.33, 119.92, 119.15, 112.98, 109.54, 76.10, 62.98, 13.85, 9.51 . 24, 153.11, 136.63, 123.81, 123.08, 119.45, 103.12, 100.61, 100.32, 76.45, 62.69, 55.04, 13.58 . 41, 154.45, 130.41, 129.72, 126.08, 112.23, 110.55, 103.19, 102.89, 76.64, 62.87, 55.63, 13.75 . 44, 156.49, 136.12, 124.20, 123.27, 121.50, 110.27, 103.47, 93.71, 76.42, 62.91, 55.53, 13.79 159.26, 156.92, 131.70, 129.63, 129.53, 127.19, 110.64, 110.55, 110.29, 105.90, 105.67, 103.35, 103.31, 76.66, 62.91, 13.58 149.19, 149.04, 148.04, 147.89, 146.79, 146.63, 145.66, 145.51, 130.40, 126.88, 124.44, 107.60, 103.57, 98.48, 76.86, 63.31, 13.73 94, 135.49, 134.74, 132.25, 129.29, 128.90, 128.76, 124.97, 122.74, 121.26, 120.71, 109.37, 104.57, 76.80 49, 146.23, 135.58, 129.78, 129.73, 129.34, 128.99, 125.00, 122.75, 121.30, 120.70, 109.40, 104.52, 76.74, 21.77 : δ 196.15, 141.05, 135.42, 133.30, 132.47, 131.59, 129.20, 129.04, 125.89, 124.93, 122.54, 121.14, 120.55, 109.50, 104.29, 77.32, 21.85 . 193.58, 145.02, 137.44, 135.40, 130.06, 129.93, 129.84, 129.20, 126.49, 124.97, 122.60, 121.17, 120.54, 109.37, 104.34, 76.58, 20.08, 19.60 . 31, 156.60, 135.44, 129.92, 129.20, 129.09, 127.06, 124.99, 122.65, 121.19, 120.61, 109.36, 104.38, 76.56, 34.18, 23.27 . 77, 159.72, 135.46, 133.33, 129.98, 129.26, 124.88, 122.81, 121.80, 121.33, 120.74, 112.50, 109.26, 104.67, 76.84, 55.25 
Analytical data
HRMS (ESI)
2-hydroxy-2-(1H-indol-1-yl)-1-(4-methoxyphenyl)ethan-1-one (4g)
1 H NMR (400 MHz, CDCl3): δ 7.71 (d, J = 8.9 Hz, 2H), 7.48 (dd, J = 15.7, 8.1 Hz, 2H), 7.18 (t, J = 7.6 Hz, 1H), 7.06 (t, J = 7.5 Hz, 1H), 6.86 (d, J = 3.3 Hz, 1H), 6.71 (d, J = 7.3 Hz, 1H), 6.66 (d, J = 8.9 Hz, 2H), 6.40 (d, J = 3.2 Hz, 1H), 5.18 (d, J = 7.3 Hz, 1H), 3.62 (s, 3H) . 13 C NMR (100 MHz, CDCl3): δ 192.05, 164.74, 135.46, 131.35, 129.20, 125.01, 124.97, 122.66, 121.23, 120.62, 114.23, 109.33, 104.36, 76.45, 55.43 85, 136.12, 135.50, 132.05, 131.32, 129.86, 129.44, 129.38, 129.30, 128.91, 127.67, 127.04, 124.98, 123.55, 122.81, 121.35, 120.74, 109.37, 104.67, 76.89 . = 7.9 Hz, 1H), 7.54 (d, J = 8.3 Hz, 1H), 7.30 (t, J = 7.7 Hz, 1H), 7.18 (t, J = 7.5 Hz, 1H), 7.02 (t, J = 8.5 Hz, 2H), 6.95 (d, J = 3.1 Hz, 1H), 6.83 (d, J = 7.2 Hz, 1H), 6.53 (d, J = 3.0 Hz, 1H), 5.11 (d, J = 7.3 Hz, 1H ). 13 C NMR (100 MHz, CDCl3): δ 192.38, 167.66, 165.09, 135.31, 131.65, 131.55, 129.22, 128.60, 128.58, 124.90, 122.81, 121.31, 120.78, 116.33, 116.11, 109.26, 104.67, 76.76 -1-yl)-1-(1-methyl-1H-pyrrol-2-yl) 135.33, 133.40, 129.12, 126.42, 125.18, 122.39, 121.10, 121.06, 120.30, 109.53, 109.48, 103.85, 76.68, 37.64 135.16, 129.10, 125.64, 121.99, 120.94, 120.21, 110.24, 103.21, 78.13, 61.73, 25.44, 18.07, 13.98, -5.32, -5.44 124.75, 121.72, 121.01, 119.92, 110.25, 102.60, 80.75, 65.83, 25.54, 17.92, -5.35, -5.57 . 3.68-3.64 (m, 2H), 3.63-3.58 (m, 2H), 3.39-3.34 (m, 2H), 3.19-3.15 (m, 2H) . 13 C NMR (150 MHz, CDCl3): δ 154. 18, 149.47, 140.42, 139.52, 137.62, 133.47, 133.45, 132.45, 130.30, 127.82, 127.43, 127.39, 127.25, 127.17, 127.04, 126.96, 125.93, 125.30, 125.02, 124.28, 122.85, 115.42, 93.30, 87.12, 85.15, 72.60, 68.21 
HRMS (ESI)
2-hydroxy-2-(1H-indol
HRMS (ESI)
6.
1 H and 13 C NMR spectra (2a-2p, 4a-4j, 5, 6, Cat-A).
Crystallographic details of 4a
Crystal data and structure refinement for Bond precision: C-C = 0.0041 A Wavelength=0. 
